Key statistics
On Friday, Lantheus Holdings Inc (0L8:DEU) closed at 98.32, -14.73% below its 52-week high of 115.30, set on Jul 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 96.32 |
---|---|
High | 98.32 |
Low | 96.32 |
Bid | 97.20 |
Offer | -- |
Previous close | 96.34 |
Average volume | 229.00 |
---|---|
Shares outstanding | 69.43m |
Free float | 67.69m |
P/E (TTM) | 18.02 |
Market cap | 7.64bn USD |
EPS (TTM) | 6.11 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
- Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
- Lantheus Appoints Julie Eastland as New Board Member
- Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
- Lantheus Reports Second Quarter 2024 Financial Results
- Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
- Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
- Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
- Lantheus Appoints Jamie Spaeth as Chief People Officer
- Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
More ▼